BreathiZen exists because the breathing-support aisle is crowded with pages that oversell botanicals and undersell honesty. We wanted the official home of our own formula to be the exception. This website is run by the team that formulates, bottles, ships and answers support mail for BreathiZen, and every page on it is written in our own voice.
What we make
One product, made properly: a five-botanical liquid drops formula — Mullein 10:1, Ginger, Bromelain, Organic Lemon and Organic Cordyceps militaris in a 154 mg daily blend — manufactured in the USA in an FDA-registered, GMP-run facility and sold in three straightforward packages with a 60-day money-back guarantee that covers opened bottles.
The six standards this site is written to
- Cautions before benefits. The blood-thinner note, the allergy hard-stops and the never-replaces-an-inhaler rule sit above the pricing on our homepage, not in a footnote.
- Badges mean what they say. We write FDA-registered facility and explain why no supplement is FDA approved — ours included.
- The label limits the claims. Where per-herb amounts are proprietary we say so and explain the trade-off rather than inventing numbers.
- Mixed letters get published. Four-star notes, flat-liners and a refund story appear on our own review page.
- Timelines are honest. Weeks, not days — and a guarantee sized to that biology.
- Sources are clickable. NCCIH, PubMed, NIH ODS, the FDA and the EPA, linked from the homepage, covering the botanicals and the general science rather than the finished product.
Corrections policy
Spot a claim these sources do not support, a price that does not match checkout, or anything else off? Write to support@breathizenmarket.com. Verified issues get fixed with a dated note — that policy is the whole reason to trust the rest of the site.
Practical details
Customer care: support@breathizenmarket.com and +1 (323) 372-9581, weekdays 9am–5pm ET. Orders are fulfilled from a US warehouse; the shipping policy and refund policy hold every logistics answer. This page was last reviewed in September 2026.